Fluorouracil and Salicylic Acid

Details

Files

Generic Name:

Project Status:

Complete

Therapeutic Area:

Hyperkeratotic actinic keratosis

Manufacturer:

Cipher Pharmaceuticals Inc.

Call for patient/clinician input open:

August 4, 2016

Brand Name:

Actikerall

Project Line:

Reimbursement Review

Project Number:

SR0498-000

Call for patient/clinician input closed:

September 23, 2016

NOC Status at Filing:

Post NOC

Performance Metric:

Achieved

Submission Type:

Initial

Indications:

Hyperkeratotic actinic keratosis

Recommendation Type:

Reimburse with clinical criteria and/or conditions

Final Recommendation:

March 22, 2017

Last Updated : August 4, 2016